Correlation Between CytomX Therapeutics and ABVC Biopharma
Can any of the company-specific risk be diversified away by investing in both CytomX Therapeutics and ABVC Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CytomX Therapeutics and ABVC Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CytomX Therapeutics and ABVC Biopharma, you can compare the effects of market volatilities on CytomX Therapeutics and ABVC Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CytomX Therapeutics with a short position of ABVC Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CytomX Therapeutics and ABVC Biopharma.
Diversification Opportunities for CytomX Therapeutics and ABVC Biopharma
0.33 | Correlation Coefficient |
Weak diversification
The 3 months correlation between CytomX and ABVC is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding CytomX Therapeutics and ABVC Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ABVC Biopharma and CytomX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CytomX Therapeutics are associated (or correlated) with ABVC Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ABVC Biopharma has no effect on the direction of CytomX Therapeutics i.e., CytomX Therapeutics and ABVC Biopharma go up and down completely randomly.
Pair Corralation between CytomX Therapeutics and ABVC Biopharma
Given the investment horizon of 90 days CytomX Therapeutics is expected to generate 1.33 times more return on investment than ABVC Biopharma. However, CytomX Therapeutics is 1.33 times more volatile than ABVC Biopharma. It trades about -0.03 of its potential returns per unit of risk. ABVC Biopharma is currently generating about -0.21 per unit of risk. If you would invest 84.00 in CytomX Therapeutics on November 18, 2024 and sell it today you would lose (4.00) from holding CytomX Therapeutics or give up 4.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
CytomX Therapeutics vs. ABVC Biopharma
Performance |
| Timeline |
| CytomX Therapeutics |
| ABVC Biopharma |
CytomX Therapeutics and ABVC Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with CytomX Therapeutics and ABVC Biopharma
The main advantage of trading using opposite CytomX Therapeutics and ABVC Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CytomX Therapeutics position performs unexpectedly, ABVC Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will offset losses from the drop in ABVC Biopharma's long position.| CytomX Therapeutics vs. Spero Therapeutics | CytomX Therapeutics vs. Instil Bio | CytomX Therapeutics vs. NextCure | CytomX Therapeutics vs. Assembly Biosciences |
| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Akari Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |